Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Mandy David, PA-C, MPH, Christopher Carroll, MD, Ashley Lauriello, NP, Benjamin Salzberg, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 856.

https://doi.org/10.1182/blood-2018-99-111435

Published: 2018

Journal Articles

Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the Grndad Registry

Matthew Sears, PhD, Sophie Lanzkron, MD MHS, Carolyn Hoppe, Joshua J. Field, MD, Payal C Desai, MD, Elizabeth Williams, Jane Little, MD

Blood (2018) 132 (Supplement 1): 158.

https://doi.org/10.1182/blood-2018-158

Published: 2018

Journal Articles

Societal Costs of Sickle Cell Disease in the United States

Irene Agodoa, MD, Deborah Lubeck, PhD, Nickhill Bhakta, MD MPH, Mark Danese, MHS, PhD, Kartik Pappu, PhD, Robin Howard, MBA, Michelle Gleeson, PhD, Marc Halperin, BA, Sophie Lanzkron, MD MHS

Blood (2018) 132 (Supplement 1): 4706.

https://doi.org/10.1182/blood-2018-99-119420

Published: 2018

Journal Articles

Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chronic Pain: A Preliminary Report from the Escaped Trial

Sophie Lanzkron, MD MHS, Carlton Haywood, Jr., PhD MA, Jane A Little, MD, Joshua Field, MD MS, Joseph Ryan Shows, MD, Jodi Segal, MD MPH, Mustapha Saheed, MD, Derek Robertson, JD, MBA, Marc V Proudford, MBA, MS, Adrienne Kincaid, Lorri Burgess, Charles Green, Hang Wang, PhD, Rebecca Seufert, BS, Jasmine Brooks, BA, Brandi Griffin, BSN, RN, Allie Piehet, BS, Steven Frymark, BA, Ravi Varadhan, PhD

Blood (2016) 128 (22): 2490.

https://doi.org/10.1182/blood.V128.22.2490.2490

Published: 2016

Journal Articles

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Mehdi Nouraie, MD PhD, Debra L Weiner, MD, Mariana Hildesheim, MS, Ward Hagar, MD, Oswaldo L Castro, MD, Sophie Lanzkron, MD MHS, Victor R. Gordeuk, MD, James F. Casella, MD, Mark T. Gladwin, MD, Gregory J. Kato, MD

Blood (2016) 128 (22): 3662.

https://doi.org/10.1182/blood.V128.22.3662.3662

Published: 2016

Journal Articles

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Shawn M Bediako, PhD, Julie Nelson, BS, Cody Cichowitz, BS, Tiffany Yu, BS, C. Patrick Carroll, MD, Kerry J. Stewart, Ed.D., Rakhi P. Naik, MD MHS, Carlton Haywood, Jr., PhD MA, Sophie Lanzkron, MD MHS

Blood (2015) 126 (23): 3405.

https://doi.org/10.1182/blood.V126.23.3405.3405

Published: 2015

Journal Articles

Contraceptive in Women with Sickle Cell Disease: A Survey Study

Natalie S Whaley, MD MPH, Sophie Lanzkron, MD MHS, Anne Burke, MD MPH

Blood (2015) 126 (23): 3263.

https://doi.org/10.1182/blood.V126.23.3263.3263

Published: 2015

Journal Articles

An Analysis of VTE Prophylaxis Practice in Oncology Patients after Implementation of a Standardized Mandatory Computerized Clinical Decision Support Tool

Anthony Serritella, Brandyn Daniel Lau, MPH, CPH, Elliott R Haut, MD, Peggy S Kraus, PharmD, Deborah Hobson, RN, Dauryne Shaffer, MSN, RN, CCRN, Victor O Popoola, MBBS MPH, Kenneth Shermock, PharmD, PhD, Sophie Lanzkron, MD MHS, Michael B. Streiff, MD

Blood (2014) 124 (21): 4859.

https://doi.org/10.1182/blood.V124.21.4859.4859

Published: 2014

Journal Articles

Successful Use of Pegylated Carboxyhemoglobin Bovine As an Emergency Treatment for Severe Anemia in a Patient with Sickle Cell Disease and Hyperhemolysis: A Case Report

Candice M Nalley, MD, Abe Abuchowski, PhD MHS, Steven Hsu, MD, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 4928.

https://doi.org/10.1182/blood.V124.21.4928.4928

Published: 2014

Journal Articles

Essential Thrombocytosis: Redefinition in the Genomic Era

Donna M. Williams, PhD, Michael A McDevitt, MD PhD, Brady L Stein, MDMHS, Ophelia Rogers, Michael B. Streiff, MD, David Neal, Sophie Lanzkron, MD MHS, Linda M. S. Resar, MD, Christine O'Keefe, PhD, Jaroslaw P. Maciejewski, MD PhD, Jerry L. Spivak, MD, Alison R. Moliterno, MD

Blood (2014) 124 (21): 3205.

https://doi.org/10.1182/blood.V124.21.3205.3205

Published: 2014

Journal Articles

Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease

Tiffany Yu, Timothy Campbell, Isabella Ciuffetelli, Carlton Haywood, PhD MA, Christopher Patrick Carroll, MD, Linda M. S. Resar, MD, John J. Strouse, MD PhD, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 2709.

https://doi.org/10.1182/blood.V124.21.2709.2709

Published: 2014

Journal Articles

Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease

Cody Cichowitz, MDcal Student, C. Patrick Carroll, MD, John J. Strouse, MD PhD, Carlton Haywood, PhD MA, Sophie Lanzkron, MD MHS

Blood (2014) 124 (21): 2717.

https://doi.org/10.1182/blood.V124.21.2717.2717

Published: 2014

Journal Articles

Patent Foramen Ovale in Adult Patients with Sickle Cell Disease and Stroke

Sheila Razdan, BA, Anusha Reddy, BS, Danielle F. Resar, John J. Strouse, MD PhD, Rani Hasan, MD, Jon R. Resar, MD, Rakhi P. Naik, MD, Sophie Lanzkron, MD MHS, Linda M. S. Resar, MD

Blood (2014) 124 (21): 4084.

https://doi.org/10.1182/blood.V124.21.4084.4084

Published: 2014

Journal Articles

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

Laura M. De Castro, MD, Ted Wun, MD, Sophie Lanzkron, MD MHS, Wally R. Smith, MD, Kathryn L. Hassell, MD, Abdullah Kutlar, MD, Kim Smith-Whitley, MD, Seungshin Rhee, MS, Marilyn J. Telen, MD, Helen Thackray, MD

Blood (2013) 122 (21): 775.

https://doi.org/10.1182/blood.V122.21.775.775

Published: 2013

Journal Articles

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Marilyn J. Telen, MD, Ted Wun, MD, Timothy L. McCavit, MD, MS, Laura M. De Castro, MD, Lakshmanan Krishnamurti, MD, Sophie Lanzkron, MD, MHS, Lewis L. Hsu, MD, PhD, Wally R. Smith, MD, Seungshin Rhee, MS, John L. Magnani, PhD, Helen Thackray, MD

Blood (2013) 122 (21): 776.

https://doi.org/10.1182/blood.V122.21.776.776

Published: 2013

Journal Articles

Perceived Discrimination In Health Care Is Associated With Daily Chronic Pain In Sickle Cell Disease

Carlton Haywood, Jr., PhD, MA, Sophie Lanzkron, MD, MHS, C. Patrick Carroll, MD, John J. Strouse, MD, PhD, Shawn M Bediako, PhD, Jennifer Haythornthwaite, PhD, Gladys T Onojobi, MD, Mary Catherine Beach, MD, MPH

Blood (2013) 122 (21): 5577.

https://doi.org/10.1182/blood.V122.21.5577.5577

Published: 2013

Journal Articles

Cost Benefit Analysis Of a Sickle Cell Infusion Center For The Treatment Of Vaso-Occlusive Crises

Meera Chappidi, Y. Natalia Alfonso, MA, David Bishai, MD, PhD, MPH, Sophie Lanzkron, MD, MHS

Blood (2013) 122 (21): 1697.

https://doi.org/10.1182/blood.V122.21.1697.1697

Published: 2013

Journal Articles

Venous Thromboembolism Incidence In The Cooperative Study Of Sickle Cell Disease: The Untold Story

Rakhi P. Naik, MD, Carlton Haywood, Jr., PhD, MA, Michael B. Streiff, MD, Sophie Lanzkron, MD, MHS

Blood (2013) 122 (21): 2214.

https://doi.org/10.1182/blood.V122.21.2214.2214

Published: 2013

Journal Articles

The Incidence of Neonatal Abstinence Syndrome in Babies Born to Women with Sickle Cell Disease: A Single Center Study

Cynthia L Anderson, MD, Karin J Blakemore, MD, Sophie Lanzkron, MD, MHS

Blood (2012) 120 (21): 3225.

https://doi.org/10.1182/blood.V120.21.3225.3225

Published: 2012

Journal Articles

Higher Baseline Hemoglobin and Splenectomy Are Risk Factors for Venous Thromboembolism in Adults with Sickle Cell Variant Genotypes

Rakhi P. Naik, MD, Michael B. Streiff, MD, Julie Nelson, Sophie Lanzkron, MD, MHS

Blood (2012) 120 (21): 3243.

https://doi.org/10.1182/blood.V120.21.3243.3243

Published: 2012

NARROW

Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine

Iron Overload Is Under-Recognized and Under-Treated in SCD: A Report from the Grndad Registry

Societal Costs of Sickle Cell Disease in the United States

Acute Care Utilization Is More Common in Patients with Sickle Cell Disease Who Have Chronic Complications and Chronic Pain: A Preliminary Report from the Escaped Trial

Hospitalization for Acute Pain in Sickle Cell Disease: Changes in Clinical Parameters and Factors Predicting Hospital Discharge and Re-Admission

Metabolic Syndrome Risk Among Adults Living with Sickle Cell Disease

Contraceptive in Women with Sickle Cell Disease: A Survey Study

An Analysis of VTE Prophylaxis Practice in Oncology Patients after Implementation of a Standardized Mandatory Computerized Clinical Decision Support Tool

Successful Use of Pegylated Carboxyhemoglobin Bovine As an Emergency Treatment for Severe Anemia in a Patient with Sickle Cell Disease and Hyperhemolysis: A Case Report

Essential Thrombocytosis: Redefinition in the Genomic Era

Avascular Necrosis: An Understudied Risk Factor for Acute Care Utilization By Patients with Sickle Cell Disease

Screening for Neurocognitive Dysfunction in an Adult Population with Sickle Cell Disease

Patent Foramen Ovale in Adult Patients with Sickle Cell Disease and Stroke

Effects Of GMI 1070, a Pan-Selectin Inhibitor, On Pain Intensity and Opioid Utilization In Sickle Cell Disease

GMI 1070: Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Prospective, Randomized, Multi-Center Double Blind, Adaptive Phase 2 Study In Sickle Cell Disease

Perceived Discrimination In Health Care Is Associated With Daily Chronic Pain In Sickle Cell Disease

Cost Benefit Analysis Of a Sickle Cell Infusion Center For The Treatment Of Vaso-Occlusive Crises

Venous Thromboembolism Incidence In The Cooperative Study Of Sickle Cell Disease: The Untold Story

The Incidence of Neonatal Abstinence Syndrome in Babies Born to Women with Sickle Cell Disease: A Single Center Study

Higher Baseline Hemoglobin and Splenectomy Are Risk Factors for Venous Thromboembolism in Adults with Sickle Cell Variant Genotypes

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only